Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsPerformance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologiesTriage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.Human Papillomavirus Laboratory Testing: the Changing ParadigmHPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningDisagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay.Human papillomavirus testing and genotyping in cervical screening.The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.Performance of mRNA- and DNA-based high-risk human papillomavirus assays in detection of high-grade cervical lesions.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Effectiveness of HPV 16 viral load and the E2/E6 ratio for the prediction of cervical cancer risk among Chinese women.HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women.[Precancerous lesions of the cervix. Biomarkers in cytological diagnosis].Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens.
P2860
Q24198236-78C7FC9F-DA0B-4741-97DD-CC2FA86ED085Q34273090-6D2444B7-4B1A-4B25-B135-C3C1F5857E34Q34330297-1F2B4AEF-0A19-4A8E-9C6E-8A58AEB2D5A8Q35108590-88C738BC-4E80-42F2-8D8E-C03F3A4F124EQ35868702-70C24A5E-0A12-4FD4-B50A-80265D85A9F1Q36675236-9E128009-DC31-4E53-B97A-2494248FD6CCQ36856284-9C744152-8D60-4D07-B08E-C8A9C4C64C28Q37264271-2FE63692-F394-42E8-B147-4B437E7C2DE4Q37470374-EAF743B8-81CE-4459-B91C-612F8FB5074DQ37496183-35483221-9813-428F-A5E9-55A9C38E386FQ37546570-87275547-3987-475F-9BA3-ADF36B336103Q37713738-175FAE9B-93AF-4FC0-97EF-0B5F2EB9E42FQ37909359-14AA5DCE-3174-4AC4-A3E7-19B2EF129E50Q38011639-1932694B-AD1B-48E6-89B3-5DED452F6069Q39177983-CA67B6D3-01D5-42B9-ABAB-E35A077C813FQ40043990-AE6B4220-BC74-43CA-A979-5BE8E174816DQ45903948-ADC5FFC1-4CAD-40FC-9507-627E387F8284Q54247283-41FD2C8C-DF9F-494C-AEE1-B3A0E25687DAQ54559907-ACEE774D-DA8C-493A-9B5D-CD4600675414Q55003928-C71D2F17-276B-4218-988C-C55D9E343B98
P2860
Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@ast
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@en
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@nl
type
label
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@ast
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@en
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@nl
prefLabel
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@ast
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@en
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@nl
P2093
P2860
P356
P1476
Performance of the Aptima high ...... Hybrid Capture 2 and cytology.
@en
P2093
Andreas Clad
Janina Rahmsdorf
Johanna Weinschenk
Miriam Reuschenbach
Nikolaus Freudenberg
Ruth Grote
P2860
P304
P356
10.1128/JCM.01674-10
P407
P577
2010-12-29T00:00:00Z